Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis: A Cross-Country Review of Access Conditions

2017 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []